Document is current
Any future updates will be listed below
-
Authors
Ebner, R. https://orcid.org/0009-0001-0851-0094
Lohse, A.
Fabritius, M. P.
Rübenthaler, J.
Wängler, C.
Wängler, B.
Schirrmacher, R.
Völter, F.
Schmid, H. P.
Unterrainer, L. M.
Öcal, O.
Hinterberger, A.
Spitzweg, C.
Auernhammer, C. J.
Geyer, T.
Ricke, J.
Bartenstein, P.
Holzgreve, A.
Grawe, F.
- License Information
-
More Information
Article History
Received: 27 November 2023
Revised: 27 February 2024
Accepted: 18 April 2024
First Online: 20 May 2024
Compliance with ethical standards
:
: The scientific guarantor of this publication is Freba Grawe.
: AH reports compensation for scientific consulting by ABX advanced biochemical compounds. CS has received honoraria for lectures and advisory boards: Bayer, Eisai, Lilly, Ipsen, Roche, and Sanofi. CJA has received research contracts (Novartis), lecture honorarium (Advanced Accelerator Applications, Ipsen, Novartis), and advisory board honorarium (Advanced Accelerator Applications). JR is a member of the Advisory Editorial Board for European Radiology (European Society for Hybrid, Molecular, and Translational Imaging). OÖ is a Junior Deputy Editor for European Radiology. The authors affiliated with European Radiology did not participate in the selection nor review processes for this article.
: No complex statistical methods were necessary for this paper.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: No study subjects or cohorts have been reported previously.
:
